0001491877-11-000015.txt : 20110527 0001491877-11-000015.hdr.sgml : 20110527 20110527164006 ACCESSION NUMBER: 0001491877-11-000015 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110525 FILED AS OF DATE: 20110527 DATE AS OF CHANGE: 20110527 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DAVIS PETER B CENTRAL INDEX KEY: 0001222789 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-04829 FILM NUMBER: 11878747 MAIL ADDRESS: STREET 1: C/O XOMA, LTD. STREET 2: 2910 SEVENTH STREET CITY: BERKELEY STATE: CA ZIP: 94710 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NABI BIOPHARMACEUTICALS CENTRAL INDEX KEY: 0000072444 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 591212264 STATE OF INCORPORATION: DE FISCAL YEAR END: 1226 BUSINESS ADDRESS: STREET 1: 12276 WILKINS AVENUE CITY: ROCKVILLE STATE: MD ZIP: 20852 BUSINESS PHONE: 301-770-3099 MAIL ADDRESS: STREET 1: 12276 WILKINS AVENUE CITY: ROCKVILLE STATE: MD ZIP: 20852 FORMER COMPANY: FORMER CONFORMED NAME: NABI BIOPHARMACEUTICALS DATE OF NAME CHANGE: 20020304 FORMER COMPANY: FORMER CONFORMED NAME: NABI /DE/ DATE OF NAME CHANGE: 19960405 FORMER COMPANY: FORMER CONFORMED NAME: NORTH AMERICAN BIOLOGICALS INC DATE OF NAME CHANGE: 19920703 4 1 edgar.xml PRIMARY DOCUMENT X0303 4 2011-05-25 0000072444 NABI BIOPHARMACEUTICALS NABI 0001222789 DAVIS PETER B PO BOX 4 QUECHEE VT 05059 1 0 0 0 Stock Option (right to buy) 5.45 2011-05-25 4 A 0 20000 0 A 2018-05-25 Common Stock 20000 20000 D The Stock Option (right to buy) is exercisable in four equal installments on August 25, 2011, November 25, 2011, February 25, 2012 and May 25, 2012. James E. Dawson, as attorney-in-fact 2011-05-27